RxSight, Inc. (RXST)
NASDAQ: RXST · IEX Real-Time Price · USD
14.25
+1.06 (8.04%)
At close:
Jan 27, 2023, 4:00 PM
14.96
+0.71 (4.98%)
After-hours:
Jan 27, 2023, 7:11 PM EST
RxSight Market Cap
RxSight has a market cap or net worth of $395.03 million as of January 29, 2023. RxSight's market cap has increased by 20.05% in one year.
Market Cap
395.03M
Enterprise Value
326.71M
1-Year Change
20.05%
Ranking
Category
Stock Price
$14.25
Market Cap Chart
Since the IPO on July 30, 2021, RxSight, Inc.'s market cap has decreased from $424.33M to $395.03M, a decrease of -6.91%. That is a compound annual growth rate of -4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2023 | 395.03M | 8.04% |
| Jan 26, 2023 | 365.65M | 2.25% |
| Jan 25, 2023 | 357.61M | 0.16% |
| Jan 24, 2023 | 357.05M | -1.08% |
| Jan 23, 2023 | 360.94M | -0.23% |
| Jan 20, 2023 | 361.77M | 1.64% |
| Jan 19, 2023 | 355.95M | 2.07% |
| Jan 18, 2023 | 348.74M | -3.31% |
| Jan 17, 2023 | 360.66M | -0.54% |
| Jan 13, 2023 | 362.60M | -1.28% |
| Jan 12, 2023 | 367.31M | -4.06% |
| Jan 11, 2023 | 382.84M | 3.29% |
| Jan 10, 2023 | 370.64M | -1.33% |
| Jan 9, 2023 | 375.63M | 4.96% |
| Jan 6, 2023 | 357.89M | 0.47% |
| Jan 5, 2023 | 356.22M | -0.31% |
| Jan 4, 2023 | 357.33M | 0.86% |
| Jan 3, 2023 | 354.28M | 0.87% |
| Dec 30, 2022 | 351.23M | 4.28% |
| Dec 29, 2022 | 336.82M | 3.49% |
| Dec 28, 2022 | 325.45M | 3.80% |
| Dec 27, 2022 | 313.53M | -4.80% |
| Dec 23, 2022 | 329.33M | -4.50% |
| Dec 22, 2022 | 344.86M | 5.33% |
| Dec 21, 2022 | 327.39M | 5.73% |
View and export this data all the way back to 2021.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics, Inc. | 1.43B |
| Sight Sciences, Inc. | 586.48M |
| Protagonist Therapeutics, Inc. | 564.31M |
| Repare Therapeutics, Inc. | 517.80M |
| MeiraGTx Holdings PLC | 313.16M |
| OrganiGram Holdings Inc. | 305.26M |
| Inventiva SA | 268.82M |
| Incannex Healthcare Limited | 206.90M |
| Nyxoah SA | 144.71M |
| Science 37, Inc. | 50.73M |